Clinical Trials Logo

Ondine Syndrome clinical trials

View clinical trials related to Ondine Syndrome.

Filter by:
  • None
  • Page 1

NCT ID: NCT06337149 Recruiting - Ondine Syndrome Clinical Trials

Relationship Between Breathing and Attention in Children With Ondine Syndrome

OndineCo
Start date: February 29, 2024
Phase:
Study type: Observational

Congenital central hypoventilation syndrome (CCHS) is a rare disorder of autonomic and respiratory regulation that alters oxygen delivery to the brain. CCHS patients are at risk for broad neurocognitive deficits. Patients retain ventilatory activity when awake through a respiratory-related cortical network but the need to mobilise cortical resources to breathe lead to breathing-cognition interferences during cognitive tasks. The purpose of this study is to assess the relationship between breathing pattern and attention in CCHS children

NCT ID: NCT03095729 Completed - Healthy Clinical Trials

Cognitive Consequences of an Activation of the Cortical Drive to Breath (VENTIPSY)

VENTIPSY
Start date: April 26, 2017
Phase:
Study type: Observational

The purpose of the study is to measure the negative cognitive consequences of the ventilation under pathological or experimental cortical drive to breath.

NCT ID: NCT01243697 Completed - Ondine Syndrome Clinical Trials

Assessment of Desogestrel in Ondine Syndrome

RESPIRONDINE
Start date: April 2011
Phase: Phase 2/Phase 3
Study type: Interventional

The congenital central hypoventilation syndrome (CCHS), also known as the Ondine syndrome, is a very rare genetic disorder. In contrast with healthy people, patients do not increase breathing in response to an excess of carbon dioxide (CO2). As a consequence, they do not breath sufficiently, or even stop breathing, during sleep. Their survival depends only on mechanical respiratory assistance, all life long. We have recently published two cases of recovery of a response to CO2 in patients taking desogestrel as a contraceptive pill. The goal of the study is therefore to assess the hypothesis that desogestrel will restore a respiratory response to CO2 in CCHS patients and allow them to breath sufficiently during sleep without mechanical assistance.